Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 11Gastrointestinal 6Other 4Lymphoid 4Dermatologic 4Genitourinary 3Thoracic 2Other hematologic neoplasm 2Plasma cell 1Other neoplasm 1Head & Neck 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1Malnutrition 1Lymphoma, Non-Hodgkin 1Huntington Disease 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Docosahexaenoic Acids × Lymphoid × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT01051154 2016-08-22

DHA-ALL

Coordinación de Investigación en Salud, Mexico

Phase 2 Completed
72 enrolled
LymphoidOther hematologic neoplasm

Malnutrition, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown
45 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00146211 2007-12-27

TREND-HD - A Trial of Ethyl-EPA (Miraxionâ„¢) in Treating Mild to Moderate Huntington's Disease

Amarin Neuroscience Ltd

Phase 3 Completed
300 enrolled
Lymphoid

Huntington Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡